204. Deputy David Cullinane asked the Minister for Health the number of medicines which entered the HSE reimbursement process in each year 2021 to 2025 and to date in 2026; the number which received a final reimbursement decision; the average, median and longest time spent at each stage from reimbursement application and pharmacoeconomic assessment to final decision; the number and duration of clock stops; the number and percentage completed within the applicable administrative or process target; and the equivalent figures separately for orphan medicines, medicines for rare diseases, oncology medicines and all other medicines, in tabular form. [67623/26]

Summary

204. Deputy David Cullinane asked the Minister for Health the number of medicines which entered the HSE reimbursement process in each year 2021 to 2025 and to date in 2026; the number which received a final reimbursement decision; the average, median and longest time spent at each stage from reimbursement application and pharmacoeconomic assessment to final decision; the number and duration of clock stops; the number and percentage completed within the applicable administrative or process target; and the equivalent figures separately for orphan medicines, medicines for rare diseases, oncology medicines and all other medicines, in tabular form. [67623/26]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 23 September 2026

   Medicinal Products

   204. Deputy David Cullinane asked the Minister for Health the number of medicines which entered the HSE reimbursement process in each year 2021 to 2025 and to date in 2026; the number which received a final reimbursement decision; the average, median and longest time spent at each stage from reimbursement application and pharmacoeconomic assessment to final decision; the number and duration of clock stops; the number and percentage completed within the applicable administrative or process target; and the equivalent figures separately for orphan medicines, medicines for rare diseases, oncology medicines and all other medicines, in tabular form. [67623/26]

   Source: written

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 23 September 2026

  ViewDownloadOpen at official source

Sponsors

• David Cullinane · Asking member
• Health · Health · Addressed to

Related records

No cross-record relationships stored yet.